Molecule Name |
DB08448
|
DrugBank Groups |
Experimental
|
Cluster No |
2596
|
Smiles |
OC5(=CC1(=C(N(C2(C=CCC=C2(C=C1)))CC4(=NC=3(C(=NC(N)=NC=3N)N=C4)))C=C5))
|
Download |
mol2, pdbqt
|
TPSA |
287,08
|
Non-H Atoms |
29
|
Non-C/H Atoms |
8
|
Metal-Atoms |
0
|
Electronegative Atoms |
8
|
Stereo Centers |
1
|
Rotatable Bonds |
2
|
Rings Closures |
5
|
Small Rings |
5
|
Aromatic Rings |
3
|
Aromatic Atoms |
16
|
sp3-Atoms |
5
|
Symmetric atoms |
0
|
cLogS |
-4,994
|
MW |
385,43
|
cLogP |
1,4685
|
HBA |
8
|
HBD |
3
|
Ro5 violations |
0
|
Druglikeness |
1,1451
|
DrugScore |
0,585082413834593
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Inhibitor
|
Renal Organic Cation Transporter |
Inhibitor
|
Aqueous solubility |
-3,3753
|
Caco-2 Permeability 2 |
1,0238
|
Subcellular localization |
Nucleus
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
Low FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,462
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,4594
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,5366
|
Carcinogenicity (Three-class) |
Non-required
|